Page last updated: 2024-10-31

neostigmine and Bronchial Pneumonia

neostigmine has been researched along with Bronchial Pneumonia in 3 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
RIETTI, E1
MacKechnie, HL1
Squires, AH1
Platts, M1
Pruzanski, W1
Edwards, FR1
Wilson, A1

Other Studies

3 other studies available for neostigmine and Bronchial Pneumonia

ArticleYear
[Capillary bronchitis in infants; beneficial effect of prostigmine in a case].
    El Dia medico, 1952, Aug-25, Volume: 24, Issue:54

    Topics: Bronchitis; Bronchopneumonia; Capillaries; Child; Humans; Infant; Neostigmine

1952
Thymoma, myasthenia gravis, erythroblastopenic anemia and systemic lupus erythematosus in one patient.
    Canadian Medical Association journal, 1973, Oct-20, Volume: 109, Issue:8

    Topics: Ambenonium Chloride; Anemia, Aplastic; Autoimmune Diseases; Bone Marrow; Bone Marrow Cells; Bronchop

1973
Thymectomy for myasthenia gravis.
    Thorax, 1972, Volume: 27, Issue:5

    Topics: Activities of Daily Living; Adolescent; Adult; Age Factors; Aged; Bronchopneumonia; Child; Female; F

1972